Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma
Open Access
- 9 April 2023
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 13 (4) , 661
Abstract
Skin cutaneous melanoma (SKCM) is a highly malignant and aggressive cancer. Previous studies have shown that cellular senescence is a promising therapeutic strategy to limit melanoma cell progression. However, models to predict the prognosis of melanoma based on senescence-related lncRNAs and the efficacy of immune checkpoint therapy remain undefined. In this study, we developed a predictive signature consisting of four senescence-related lncRNAs (AC009495.2, U62317.1, AATBC, MIR205HG), and we then classified patients into high- and low-risk groups. GSEA (Gene set enrichment analysis) showed different activation of immune-related pathways in two groups. In addition, there were significant differences between the scores of tumor immune microenvironment, tumor burden mutation, immune checkpoint expression, and chemotherapeutic drug sensitivity between the two groups of patients. It provides new insights to guide more personalized treatment for patients with SKCM.Keywords
Funding Information
- the President of Nanfang Hospital of Southern Medical University (2021A006)
This publication has 36 references indexed in Scilit:
- Long Noncoding RNA and Cancer: A New ParadigmCancer Research, 2017
- The Immune Biology of Microsatellite-Unstable CancerTrends in Cancer, 2016
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- limma powers differential expression analyses for RNA-sequencing and microarray studiesNucleic Acids Research, 2015
- Cellular senescence: from physiology to pathologyNature Reviews Molecular Cell Biology, 2014
- The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic NeoplasiaAnnual Review of Pathology: Mechanisms of Disease, 2014
- Inferring tumour purity and stromal and immune cell admixture from expression dataNature Communications, 2013
- Evidence‐based treatment of early‐stage melanomaJournal of Surgical Oncology, 2011
- Melanoma and the tumor microenvironmentCurrent Oncology Reports, 2008
- What is principal component analysis?Nature Biotechnology, 2008